Lucentis now listed on the PBS

What does that mean for patients?

Julie Heraghty, CEO, Macular Disease Foundation Australia said, “This is an outstanding result for patients currently needing treatment for these sight-threatening diseases. To now have access to this highly effective treatment via the PBS will greatly improve the health outcomes of Australians both now and into the future.”
For more info see the link below
http://www.mdfoundation.com.au/page1220296.aspx